Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous stem cell transplantation plus interferon-alpha versus interferon-alpha alone after CVP induction in advanced follicular non-Hodgkin lymphoma
ISRCTN81939169Phase 3Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 1997
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, open-label trial of interferon alfa, cyclophosphamide, vincristine and prednisolone in follicular lymphoma (FL) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoints: progression-free survival, overall survival and 2 more. Started Mar 1997; status: terminated.
02
Drugs
interferon alfacyclophosphamidevincristineprednisolone
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on ISRCTN81939169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN81939169.